Incidence and Survival of Patients with Waldenstrom Macroglobulinemia Treated at The National Cancer Institute in Peru from 1999 to 2018

被引:0
|
作者
Vasquez, Jule [1 ]
Pena, Estefania [1 ]
Poquioma, Ebert [2 ]
机构
[1] Inst Nacl Enfermedades Neoplas, Dept Med Oncol, Lima, Peru
[2] Inst Nacl Enfermedades Neoplas, Dept Epidemiol, Lima, Peru
来源
关键词
IBCL; Waldenstrom macroglobulinemia; incidence; survival;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IBCL-060
引用
收藏
页码:S400 / S400
页数:1
相关论文
共 50 条
  • [1] Clinical Characteristics and Survival of Patients with Hairy Cell Leukemia Treated at the National Cancer Institute in Peru from 1999 to 2018
    Pena, Estefania
    Vasquez, Jule
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S399 - S400
  • [2] Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenstrom Macroglobulinemia Treated With Nucleoside Analogs
    Leleu, Xavier
    Soumerai, Jacob
    Roccaro, Aldo
    Hatjiharissi, Evdoxia
    Hunter, Zachary R.
    Manning, Robert
    Ciccarelli, Bryan T.
    Sacco, Antonio
    Ioakimidis, Leukothea
    Adamia, Sophia
    Moreau, Anne-Sophie
    Patterson, Christopher J.
    Ghobrial, Irene M.
    Treon, Steven P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 250 - 255
  • [3] Epidemiology and Survival of Patients with Marginal Zone Lymphoma Treated at the National Cancer Institute of Peru. a Retrospective Analysis of 187 Cases
    Vasquez, Jule F.
    Meza, Jessica
    Wendy, Melanie
    Castro-Mollo, Melanie Wendy
    Pena-Lopez, Estefania
    Lopez Chavez, Lourdes Isabel
    Mallma Soto, Victor Ivan
    Alcarraz, Cindy
    Vidaurre, Tatiana
    Quintana, Shirley
    [J]. BLOOD, 2023, 142
  • [4] Incidence and survival of Hodgkin lymphoma patients treated at a national cancer center in a middle-income country from 1999-2018: A report of 1,382 cases.
    Chavez, Jule Franve Vasquez
    Zapata, Arturo
    Garcia, Juan Luis
    Barrionuevo, Carlos
    Diaz, Edgar
    Poquioma, Ebert
    Vidaurre, Tatiana
    Malpica, Luis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Smoldering Waldenstrom's macroglobulinemia (SWM): Analysis from the National Cancer Database (NCDB)
    Pophali, Priyanka Avinash
    Bartley, Adam C.
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Ashrani, Aneel A.
    Marshall, Ariela L.
    Siddiqui, Mustaqeem Ahmad
    Go, Ronald S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group
    Chen, Christine I.
    Kouroukis, C. Tom
    White, Darrell
    Voralia, Michael
    Stadtmauer, Edward
    Stewart, A. Keith
    Wright, John J.
    Powers, Jean
    Walsh, Wendy
    Eisenhauer, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1570 - 1575
  • [7] Demographic, treatment, and survival patterns in Hispanic vs. non-Hispanic patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia: A national retrospective analysis from the National Cancer Database
    Fierro, Maria Elena
    Latiolais, Heidi
    Liu, Qianquian
    Michalek, Joel
    Duque, Adolfo Enrique Diaz
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Bortezomib is active in Waldenstrom's Macroglobulinemia (WM) - Results of a National Cancer Institute of Canada (NCIC) phase II study in previously untreated or treated WM.
    Chen, C. I.
    Kouroukis, T.
    White, D.
    Voralia, M.
    Stadtmauer, E.
    Wright, J.
    Powers, J.
    Eisenhauer, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 432S - 432S
  • [9] Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017
    Chaulagain, Chakra P.
    Landau, Kevin
    Liang, Hong
    Fu, Chieh-Lin
    [J]. BLOOD, 2022, 140 : 9333 - 9334
  • [10] Survival in Patients with Early Breast Cancer Treated with Conservative Surgery and Radiotherapy at the National Cancer Institute of Colombia
    Ospino, Rosalba
    Cendales, Ricardo
    Sanchez, Zayda
    Bobadilla, Ivan
    Galvis, Juan
    Cifuentes, Javier
    [J]. REVISTA COLOMBIANA DE CANCEROLOGIA, 2011, 15 (02): : 75 - 84